Description
The vector of anti-AMIGO2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target Human AMIGO2. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-AMIGO2 antibody linked to CD28 and CD3ζ signaling domains. And the vector product was designed for the treatment of prostate cancer